Answers are grounded in this paper and cite their sources.
Bans on endocrine-disrupting Bisphenol A (BPA) in several regions have spurred significant increases in the use of its substitutes, Bisphenol S (BPS) and Bisphenol F (BPF). The kidney is a well-established target of BPA-induced injury. However, the role of bisphenols (BPs) in senescence, which is a critical risk factor for renal diseases, remains understudied. Using National Health and Nutrition Examination Survey (NHANES) data, we initially explored associations between BPs and renal biomarkers and biological age (BA), subsequently validating our findings in rats and HK-2 cells. NHANES results indicated positive correlations of BPF with blood urea nitrogen (BUN), serum creatinine (SCr), and uric acid (UA), a negative correlation with eGFR, and a significant positive correlation with renal BA acceleration. In animal experiments, rats were treated with different BPF doses, and compared its toxicity with that of a BPA group. β-gal staining was primarily localized to renal tubular epithelial cells (RTECs) post-treatment. Additionally, BPF induced a more pronounced senescent effect than BPA, with toxicity exhibiting a dose-dependent pattern. In HK-2 cells, our mechanistic investigations revealed that BPF triggers the release of mitochondrial DNA (mtDNA) into the cytoplasm, leading to elevated activation of the cGAS-STING pathway, which ultimately induces cellular senescence.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: